The role of NPY in metabolic homeostasis: implications for obesity therapy

Author： Wieland H.A.   Hamilton B.S.   Krist B.   Doods H.N.  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.9, Iss.6, 2000-06, pp. : 1327-1346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Angiotensin in Obesity and Metabolic Disease

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 3, 2011-09 ,pp. : 198-205

Bentham Science Publishers

Access to resources Recommend Favorite

Dyslipidemia in Visceral Obesity: Mechanisms, Implications, and Therapy

By Dick C. Chan   Hugh P.R. Barrett   Gerald F. Watts  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 227-246

Adis International

Access to resources Recommend Favorite

The role of dopamine in motivation for food in humans: implications for obesity

By Wang Gene-Jack   Volkow Nora D   Fowler Joanna S  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 601-609

Informa Healthcare

Access to resources Recommend Favorite

The Role of NPY and Ghrelin in Anorexia Nervosa

By  

Current Pharmaceutical Design, Vol. 18, Iss. 31, 2012-10 ,pp. : 4766-4778

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Angiotensin System in Cardiac Glucose Homeostasis: Therapeutic Implications

By Bernobich E.  

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1295-1314

Adis International

Access to resources Recommend Favorite